Atlas Trials

Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome

Clinical trial NCT00527566 · COMPLETED

Trial details

NCT number
NCT00527566
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Churg Strauss Syndrome
Start date
2007-09-01
Primary completion
2009-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.